These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10203056)
1. Restoration of the immune system with anti-retroviral therapy. Autran B; Carcelaint G; Li TS; Gorochov G; Blanc C; Renaud M; Durali M; Mathez D; Calvez V; Leibowitch J; Katlama C; Debré P Immunol Lett; 1999 Mar; 66(1-3):207-11. PubMed ID: 10203056 [TBL] [Abstract][Full Text] [Related]
2. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894 [TBL] [Abstract][Full Text] [Related]
3. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Li TS; Tubiana R; Katlama C; Calvez V; Ait Mohand H; Autran B Lancet; 1998 Jun; 351(9117):1682-6. PubMed ID: 9734884 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART). Gougeon ML; Lecoeur H; Sasaki Y Immunol Lett; 1999 Mar; 66(1-3):97-103. PubMed ID: 10203040 [TBL] [Abstract][Full Text] [Related]
5. [Antiretroviral therapy and immune reconstitution]. Carcelain G; Li TS; Renaud M; Blanc C; Tubiana R; Calvez V; Leibowitch J; Debré P; Agut H; Katlama C; Autran B J Soc Biol; 1999; 193(1):5-10. PubMed ID: 10851549 [TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. Mezzaroma I; Carlesimo M; Pinter E; Alario C; Sacco G; Muratori DS; Bernardi ML; Paganelli R; Aiuti F AIDS; 1999 Jul; 13(10):1187-93. PubMed ID: 10416521 [TBL] [Abstract][Full Text] [Related]
7. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. Wendland T; Furrer H; Vernazza PL; Frutig K; Christen A; Matter L; Malinverni R; Pichler WJ AIDS; 1999 Oct; 13(14):1857-62. PubMed ID: 10513643 [TBL] [Abstract][Full Text] [Related]
8. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. Lederman MM; Connick E; Landay A; Kuritzkes DR; Spritzler J; St Clair M; Kotzin BL; Fox L; Chiozzi MH; Leonard JM; Rousseau F; Wade M; Roe JD; Martinez A; Kessler H J Infect Dis; 1998 Jul; 178(1):70-9. PubMed ID: 9652425 [TBL] [Abstract][Full Text] [Related]
9. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients. Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364 [TBL] [Abstract][Full Text] [Related]
10. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. Giorgi JV; Majchrowicz MA; Johnson TD; Hultin P; Matud J; Detels R AIDS; 1998 Oct; 12(14):1833-44. PubMed ID: 9792384 [TBL] [Abstract][Full Text] [Related]
11. Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment. Chougnet C; Fowke KR; Mueller BU; Smith S; Zuckerman J; Jankelevitch S; Steinberg SM; Luban N; Pizzo PA; Shearer GM AIDS; 1998 Dec; 12(18):2397-406. PubMed ID: 9875577 [TBL] [Abstract][Full Text] [Related]
12. Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count. Rizzardi GP; Tambussi G; Bart PA; Chapuis AG; Lazzarin A; Pantaleo G AIDS; 2000 Oct; 14(15):2257-63. PubMed ID: 11089613 [TBL] [Abstract][Full Text] [Related]
13. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. Gray CM; Schapiro JM; Winters MA; Merigan TC AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710 [TBL] [Abstract][Full Text] [Related]
14. Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient. Li TS; Tubiana R; Fillet AM; Autran B; Katlama C J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):514-5. PubMed ID: 10225236 [No Abstract] [Full Text] [Related]
15. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. Lederman MM; McKinnis R; Kelleher D; Cutrell A; Mellors J; Neisler M; Cooney E; Haas DW; Haubrich R; Stanford J; Horton J; Landay A; Spreen W AIDS; 2000 Dec; 14(17):2635-42. PubMed ID: 11125881 [TBL] [Abstract][Full Text] [Related]
16. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection. Pontesilli O; Kerkhof-Garde S; Pakker NG; Notermans DW; Roos MT; Klein MR; Danner SA; Miedema F Immunol Lett; 1999 Mar; 66(1-3):213-7. PubMed ID: 10203057 [TBL] [Abstract][Full Text] [Related]
17. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection. Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207 [TBL] [Abstract][Full Text] [Related]
18. CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy. Meroni L; Varchetta S; Manganaro D; Moscatelli G; Moroni M; Galli M AIDS; 1999 Apr; 13(5):621-2. PubMed ID: 10203388 [No Abstract] [Full Text] [Related]
19. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278 [TBL] [Abstract][Full Text] [Related]
20. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Fleury S; de Boer RJ; Rizzardi GP; Wolthers KC; Otto SA; Welbon CC; Graziosi C; Knabenhans C; Soudeyns H; Bart PA; Gallant S; Corpataux JM; Gillet M; Meylan P; Schnyder P; Meuwly JY; Spreen W; Glauser MP; Miedema F; Pantaleo G Nat Med; 1998 Jul; 4(7):794-801. PubMed ID: 9662370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]